comprehensive -WSS

comprehensive

author：hotspot 2025-09-07 14:03:04 - browse：6742

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The Danish pharmaceutical company Novo Nordisk has shepherded all kinds of medical innovation in the 110 years since it was founded. But the booming success of its diabetes and obesity drug is unlike anything executives have seen before.

The company’s mid-year operating profit jumped from 37.5 billion Danish kroner in 2022 to 48.9 billion Danish kroner this year — “probably the strongest growth in the history of the company,” Chief Financial Officer Karsten Munk Knudsen said during an August earnings call. The 30% growth rate came from sales of semaglutide, which Novo Nordisk sells for diabetes under the name Ozempic and for obesity as Wegovy.

With its new blockbuster drug in hand, Novo Nordisk is valued higher than the entire economy of Denmark, where it’s based.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： FDA cancer chief on how to get things done: ‘Don’t tell anybody'

focus

WSS

What is STAT's opinion section for?

Cancer diagnosis changes perspective doctor, former hospital CEO

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Medical school prerequisites are outdated

EU fines Illumina $475 million over Grail acquisition

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Wikipedia

comprehensive

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Inflation cooled significantly in June, bringing price hikes close to normal levels

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

NIH chief: government has fallen behind pharma on clinical trials

Apple is now the first public company to be valued at $3 trillion

Carbon Health diabetes program, a test of data

Medicare proposal to cover medical devices draws a mixed reaction

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

leisure time

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Medical school prerequisites are outdated

Weight loss drugs should be covered by insurers, AMA says

How are insurers handling Leqembi and related scans?

What is STAT's opinion section for?

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

hotspot

focus

focus

focus